Today we’re presenting Trillion Dollar Shot, a new series that explores the business story behind the rise of Ozempic and other blockbuster drugs being used for weight loss. The first episode focuses on the Novo Nordisk scientist who invented the compound that paved the way for Ozempic. You can find every episode on The Journal’s show feed.
Trillion Dollar ... Show More
Sep 3
Protein-Maxxing: Is It Actually Bad For Us?
Protein is everywhere — tons of us are trying to cram more of it into our diets, and it's showing up in our lattes, our snack bars, even our popcorn. But just as we’re getting on board with protein-maxxing, a bunch of headlines have started saying the opposite: that eating LESS p ... Show More
31m 11s
Aug 27
Sunscreen: Could It Be Toxic??
Sunscreen is supposed to protect us from dangerous stuff like cancer, but all over social media, people are saying that we’ve been getting it all wrong. We’re being told that our sunscreen is full of toxic chemicals, that wearing it could mess with our vitamin D levels — even tha ... Show More
50m 52s
Aug 20
Hank Green: What No One Tells You About the Algorithm
Hank Green is one of the most beloved science creators on the interwebs. He’s been making videos for almost 20 years, spanning LOTS of eras of the Internet, from YouTube prank videos to TikTok dance challenges to AI slop. In this episode, Wendy sits down with Hank to talk about t ... Show More
52m 44s
Mar 2024
The Scientific Journey Behind Ozempic (with Lotte Bjerre Knudsen, Novo Nordisk's Chief Scientific Advisor)
On our Novo Nordisk episode, we covered the business of Ozempic, the GLP-1 taking the world by storm. On this episode, we dive into the science of the molecule semaglutide (and its predecessor liraglutide) with the world expert on the topic, Lotte Bjerre Knudsen. Lotte is Novo No ... Show More
58m 12s
Feb 2024
The Big Business Behind Weight Loss Drugs
It’s become a multibillion-dollar business: weight loss drugs. Demand is high, as is the cost. How did medications like Ozempic, Wegovy, Mounjaro and Zepbound become so popular and so profitable? And what kind of impact might they have on the future of food and healthcare? Dr. Sa ... Show More
33m 54s
Apr 2023
Encore: Diet Wars | Dieting 3.0 | 5
First there was Weight Watchers, then there was Noom, and now there’s…Wegovy? Bloomberg health reporter Emma Court helps us understand the evolution of dieting programs and where they’re going next. Later, Matthew Schnier of New York Magazine and The Cut walks us through his arti ... Show More
39m 12s
<p>Ozempic is being hailed as “the end of the Obesity Epidemic.” This week, Mike and Aubrey dig through the sensational claims. But will they make it past the caveats?<br/><br/><b>Links:</b> </p><ul><li><a href='https://globalnews.ca/news/9793403/ozempic-canada-scientist-venomous ... Show More
